Accupril news from FiercePharma
NewsALSO NOTED: Teva's Accupril gets FDA OK; Elder Pharmaceuticals buys Biomeda;
> Teva has nabbed an OK from the FDA for its generic form of Accupril, Pfizer's high blood pressure remedy. Total U.S. sales of the drug--branded and generic forms--amounted to $150 million for Read more...
| Press ReleasesPRESS RELEASE: Teva Announces Approval of Generic Accupril Tablets Teva Announces Approval of Generic Accupril Tablets JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. announced today that, following the expiration of pediatric exclusivity Read more... |
Get more Accupril coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight